128 related articles for article (PubMed ID: 12676983)
1. Directed evolution of a single-chain class II MHC product by yeast display.
Starwalt SE; Masteller EL; Bluestone JA; Kranz DM
Protein Eng; 2003 Feb; 16(2):147-56. PubMed ID: 12676983
[TBL] [Abstract][Full Text] [Related]
2. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
Gardiner A; Richards KA; Sant AJ; Arneson LS
Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
[TBL] [Abstract][Full Text] [Related]
3. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.
Harrison LC; Honeyman MC; Trembleau S; Gregori S; Gallazzi F; Augstein P; Brusic V; Hammer J; Adorini L
J Exp Med; 1997 Mar; 185(6):1013-21. PubMed ID: 9091575
[TBL] [Abstract][Full Text] [Related]
4. Directed evolution of soluble single-chain human class II MHC molecules.
Esteban O; Zhao H
J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of the binding of MHC class II-derived peptides to MHC class II.
Feili-Hariri M; Kao H; Mietzner TA; Morel PA
Int Immunol; 1996 Dec; 8(12):1857-65. PubMed ID: 8982770
[TBL] [Abstract][Full Text] [Related]
6. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
7. Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface.
Bhatnagar A; Milburn PJ; Lobigs M; Blanden RV; Gautam AM
J Immunol; 2001 Apr; 166(7):4490-7. PubMed ID: 11254705
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel strategy for engineering high-affinity proteins by yeast display.
Richman SA; Healan SJ; Weber KS; Donermeyer DL; Dossett ML; Greenberg PD; Allen PM; Kranz DM
Protein Eng Des Sel; 2006 Jun; 19(6):255-64. PubMed ID: 16549400
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.
Zhang L; Crawford F; Yu L; Michels A; Nakayama M; Davidson HW; Kappler JW; Eisenbarth GS
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2656-61. PubMed ID: 24550292
[TBL] [Abstract][Full Text] [Related]
10. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
11. A yeast display system for engineering functional peptide-MHC complexes.
Brophy SE; Holler PD; Kranz DM
J Immunol Methods; 2003 Jan; 272(1-2):235-46. PubMed ID: 12505727
[TBL] [Abstract][Full Text] [Related]
12. Two MHC surface amino acid differences distinguish foreign peptide recognition from autoantigen specificity.
Basu D; Horvath S; O'Mara L; Donermeyer D; Allen PM
J Immunol; 2001 Mar; 166(6):4005-11. PubMed ID: 11238647
[TBL] [Abstract][Full Text] [Related]
13. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
14. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
[TBL] [Abstract][Full Text] [Related]
15. Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7).
Münz C; Hofmann M; Yoshida K; Moustakas AK; Kikutani H; Stevanoviç S; Papadopoulos GK; Rammensee HG
Eur J Immunol; 2002 Aug; 32(8):2105-16. PubMed ID: 12209622
[TBL] [Abstract][Full Text] [Related]
16. A previously unappreciated polymorphism in the beta chain of I-A
Richards KA; Lavery C; Keller GLJ; Miller J; Baker BM; Sant AJ
Mol Immunol; 2022 Mar; 143():17-26. PubMed ID: 34995990
[TBL] [Abstract][Full Text] [Related]
17. Production of soluble MHC class II proteins with covalently bound single peptides.
Kozono H; White J; Clements J; Marrack P; Kappler J
Nature; 1994 May; 369(6476):151-4. PubMed ID: 8177320
[TBL] [Abstract][Full Text] [Related]
18. Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation.
Nydam T; Wade TK; Yadati S; Gabriel JL; Barisas BG; Wade WF
Int Immunol; 1998 Aug; 10(8):1237-49. PubMed ID: 9723711
[TBL] [Abstract][Full Text] [Related]
19. Cell surface display of functional human MHC class II proteins: yeast display versus insect cell display.
Wen F; Sethi DK; Wucherpfennig KW; Zhao H
Protein Eng Des Sel; 2011 Sep; 24(9):701-9. PubMed ID: 21752831
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice.
Levisetti MG; Suri A; Vidavsky I; Gross ML; Kanagawa O; Unanue ER
Int Immunol; 2003 Dec; 15(12):1473-83. PubMed ID: 14645156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
